69 related articles for article (PubMed ID: 27994729)
1. Macrocyclic Inhibitors of ERK2 Kinase.
Rosse G
ACS Med Chem Lett; 2016 Dec; 7(12):1020-1021. PubMed ID: 27994729
[No Abstract] [Full Text] [Related]
2. Mitogen-activated protein kinase activation during IgG-dependent phagocytosis in human neutrophils: inhibition by ceramide.
Suchard SJ; Mansfield PJ; Boxer LA; Shayman JA
J Immunol; 1997 May; 158(10):4961-7. PubMed ID: 9144515
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP
Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991
[TBL] [Abstract][Full Text] [Related]
4. Obligate mitogen-activated protein kinase activation in parathyroid hormone stimulation of calcium transport but not calcium signaling.
Sneddon WB; Liu F; Gesek FA; Friedman PA
Endocrinology; 2000 Nov; 141(11):4185-93. PubMed ID: 11089552
[TBL] [Abstract][Full Text] [Related]
5. ERK2 mediates oxytocin-stimulated PGE2 synthesis.
Strakova Z; Copland JA; Lolait SJ; Soloff MS
Am J Physiol; 1998 Apr; 274(4):E634-41. PubMed ID: 9575824
[TBL] [Abstract][Full Text] [Related]
6. Extracellular signal-regulated kinases 1 and 2 activation in endothelial cells exposed to cyclic strain.
Ikeda M; Takei T; Mills I; Kito H; Sumpio BE
Am J Physiol; 1999 Feb; 276(2 Pt 2):H614-22. PubMed ID: 9950863
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells.
Gorin Y; Ricono JM; Wagner B; Kim NH; Bhandari B; Choudhury GG; Abboud HE
Biochem J; 2004 Jul; 381(Pt 1):231-9. PubMed ID: 15027896
[TBL] [Abstract][Full Text] [Related]
8. Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin.
Liu Y; Suzuki YJ; Day RM; Fanburg BL
Circ Res; 2004 Sep; 95(6):579-86. PubMed ID: 15297378
[TBL] [Abstract][Full Text] [Related]
9. Physiological concentrations of divalent magnesium ion activate the serine/threonine specific protein kinase ERK2.
Waas WF; Dalby KN
Biochemistry; 2003 Mar; 42(10):2960-70. PubMed ID: 12627962
[TBL] [Abstract][Full Text] [Related]
10. A scintillation proximity assay for the Raf/MEK/ERK kinase cascade: high-throughput screening and identification of selective enzyme inhibitors.
McDonald OB; Chen WJ; Ellis B; Hoffman C; Overton L; Rink M; Smith A; Marshall CJ; Wood ER
Anal Biochem; 1999 Mar; 268(2):318-29. PubMed ID: 10075822
[TBL] [Abstract][Full Text] [Related]
11. Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors.
Spirin P; Lebedev T; Orlova N; Morozov A; Poymenova N; Dmitriev SE; Buzdin A; Stocking C; Kovalchuk O; Prassolov V
Oncotarget; 2017 Aug; 8(34):56991-57002. PubMed ID: 28915648
[TBL] [Abstract][Full Text] [Related]
12. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
13. Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-Raf.
Nadal-Wollbold F; Pawlowski M; Lévy-Toledano S; Berrou E; Rosa JP; Bryckaert M
FEBS Lett; 2002 Nov; 531(3):475-82. PubMed ID: 12435596
[TBL] [Abstract][Full Text] [Related]
14. Nuclear shuttling of mitogen-activated protein (MAP) kinase (extracellular signal-regulated kinase (ERK) 2) was dynamically controlled by MAP/ERK kinase after antigen stimulation in RBL-2H3 cells.
Furuno T; Hirashima N; Onizawa S; Sagiya N; Nakanishi M
J Immunol; 2001 Apr; 166(7):4416-21. PubMed ID: 11254696
[TBL] [Abstract][Full Text] [Related]
15. N-methyl-D-aspartate receptor activation results in regulation of extracellular signal-regulated kinases by protein kinases and phosphatases in glutamate-induced neuronal apototic-like death.
Jiang Q; Gu Z; Zhang G; Jing G
Brain Res; 2000 Dec; 887(2):285-92. PubMed ID: 11134617
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.
Eblen ST; Catling AD; Assanah MC; Weber MJ
Mol Cell Biol; 2001 Jan; 21(1):249-59. PubMed ID: 11113199
[TBL] [Abstract][Full Text] [Related]
17. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation.
Robinson MJ; Stippec SA; Goldsmith E; White MA; Cobb MH
Curr Biol; 1998 Oct; 8(21):1141-50. PubMed ID: 9799732
[TBL] [Abstract][Full Text] [Related]
18. Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine.
Ortiz J; Harris HW; Guitart X; Terwilliger RZ; Haycock JW; Nestler EJ
J Neurosci; 1995 Feb; 15(2):1285-97. PubMed ID: 7532701
[TBL] [Abstract][Full Text] [Related]
19. Slow inhibition and conformation selective properties of extracellular signal-regulated kinase 1 and 2 inhibitors.
Rudolph J; Xiao Y; Pardi A; Ahn NG
Biochemistry; 2015 Jan; 54(1):22-31. PubMed ID: 25350931
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates mitogen-activated protein kinase (MAPK) in cultured rat astrocytes.
Moroo I; Tatsuno I; Uchida D; Tanaka T; Saito J; Saito Y; Hirai A
Brain Res; 1998 Jun; 795(1-2):191-6. PubMed ID: 9622627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
